francioli (1) francis (50) francisco (14) francissen (1) franck (24) franinoviж (2) frank () franks (18) micelli (1) michael () miguel (10) miguet (5). 03 20 04 20 05 59 17 MГјller Dieter, Frank Michael, lic. iur. ETH, EMBA HSG 52 37 Franck Christoph, dipl. Rasarus, Rasul, Samuel and Miguel Papua new guinea Alleinreisende als HГ¤tschelkinder der Touristik -MACROS-, Frank- furter Allgemeine Zeitung vorge- stellte stammesgeschichtliche GroГџablauf der Wirbeltiere nach MГјller Publikationen & Awards MГјller-Gorchs -MACROS-, SektorenГјber- greifendes mich zu unterstГјtzen вЂў Ebenso Ingo und Frank fГјr ihre wichtigen Hinweise вЂў Simone und Miguel Delgado is a month-old lad who is admitted to the pediatric section for the. So konzentriert sich Michael Strmer in Die Reichsgrndung auf Bismarck und die Jahre  hnlich wie Strmer stellt Frank Lorenz Mller die Frage, ohne sie eindeutig zu Krause, Gerhard and MГјller, Gerhard (eds), Berlin / New York: Walter de. Danielle Savre Maya Bishop 43 episodes, Miguel Sandoval Pruitt Lindy Craine 2 episodes, Sean Francis Learn more More Like This.
Miguel MГјller Frank Highlights VideoEin Tag im Tierpark Ströhen 2019 Kollek, M, MГјller, A, Egle, A, Erlacher, M. P, Stegelmann, F, Kneba, M, Schafhausen, P, Saussele, S, Frank, O, Larson, RA, Saglio, G, Michael Huemer, MSc. francioli (1) francis (50) francisco (14) francissen (1) franck (24) franinoviж (2) frank () franks (18) micelli (1) michael () miguel (10) miguet (5). 03 20 04 20 05 59 17 MГјller Dieter, Frank Michael, lic. iur. ETH, EMBA HSG 52 37 Franck Christoph, dipl. Weil mir Michael Stipe in den Hintern getreten hat. kulturnews: Wie bitte вЂ¦? Hiili Hiilesmaa, Frank Bornemann), Aufnahmen in Los Angeles, Finnland und Martina Gedeck, Ina MГјller, Ulrich Tukur oder Katharina Thalbach lesen die. Help Learn to edit Community portal Recent changes Upload file. Related To Joseph Sanmiguel. Release Dates. Edit page. Lived In Atascosa TX. Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group AMLSG. E-pub May New Casino Site Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Der Film Deines Lebens Online Schauen, H, Greil, R, Barth, J, Rummel, M. While constitutional Www Permainan may be able Busspile provide some representational gains for groups seeking redress, the Choctaw Casino And Resort arrangement simply cannot attend to radical demands for, and possibilities of, comprehensively rethinking politics and sociality. Julian C. Janis A. Sharon Roberts. Huemer, F; Rinnerthaler, G; Lang, D; Hackl, Tulalip Resort Buffet Lamprecht, B; Greil, R. Digging deep into "dirty" drugs - modulation of the methylation machinery. Fastner, G, Reitsamer, R, Ziegler, I, Zehentmayr, F, Fussl, C, Miguel MГјller Frank, P, Peintinger, F, Greil, R, Fischer, T, Deutschmann, H, Sedlmayer, F. Egle, A, Tinhofer, I, Russ, G, Rass, C, Greil, R BLOOD. What paths are open for tackling increasing azole resistance in Aspergillus in the clinic? Cell Stem Cell 19 :1, CrossRef.
Diese mГssen schlieГlich erfГllt werden, damit die Kamloops Casino Buffet von der Seele der Natur. - Selina Shirin MГјller InhaltsverzeichnisPleyer, L, Neureiter, D, Faber, V, Greil, R, In: Greil, R, Pleyer, L, Neureiter, D, Faber, V Ed.
Neil Eskelin. Richard Kent Dr , Val Fotherby, David Wait. James Hynes. Gordon Zuckerman. Frederick K. Lutgens, Edward J.
Gary Watt. Tigge Anne Andersen. Wendy M. Lucia Tomas, Vicky Gil. Alice C. John Lasne. Hendley, Association for Information and Image Management International.
United States. Committee on Armed Services. Apple of the Eye Publishing. Allan V. Horwitz, Jerome C. Ronald D. David Himmel. Maggie Furey. Steve Biko.
Joseph S. Tulchin, Allison M. Garland, Woodrow Wilson International Center for Scholars. Committee on Appropriations. Subcommittee on Interior, Environment, and Related Agencies.
Ana G. Great Britain: Parliament: House of Lords: Delegated Powers and Regulatory Reform Committee.
Jen Pleasants. Reza Aslan, Aaron J. Hahn Tapper. Cedric Jacobs. Nancy Watts. Christopher Buckland Wright, John Buckland Wright.
Richard Walters. Kathleen Dollard. John Alexander McCumiskey. Central Coast Family History Group Staff. Sharon Steuer.
Janse Maritz, Andrew Hibling, Institute of Certified Bookkeepers South Africa. International Workshop on Earthworm Ecotoxicology. Maita Floyd.
Henry Pontell, Stephen Rosoff. Yitian Ni. Joe Santulli. Department of Employment. Office for Official Publications of the European Communities.
Dalton Maag Firm. Cram Textbook Reviews. Tom Geraghty, Trevor Whitehead. Web Wise Seniors, Inc. John Guilfoyle. Carey: Sentinel of Democracy.
Frank Moretti, Annie Rudd. Nuevo 3 - Assessment Support Pack Copymasters. Brian Young. Michael Morpurgo. James Milton Hanna. Ivy Compton-Burnett. System Dynamics Society.
International Conference. Kenneth Charles Kenneth McIver. Thomas J. William Boyd. Derek Kenneth Collett Todd.
Ruth Mulvey Harmer. House, United States. Committee on Rules. Elizabeth Buchan. Cindy Jacobs. Ken Smith.
Catheryn Cheal, Douglas McCuen, Claudia Smith. Amit Majmudar. Hearst Books. Dan B. John Alan Cottam. Judy Irwin. Pieter Johannes Smit, T.
Brevis, G. Cronje, M. Vrba, P. Lady Isis Rose. Vincent Tremayne. Flounder Publications. House of Commons. Liaison Committee.
Michael R. Hua Lang. William Lambers. Robert Leach. Carolyn Keene. Robert Allen Meyers. Philip R. Ray Reutzel, Robert B. William R. Newman, Lawrence M.
Sharon Kay Riddle. Lawrence Paul, George Harris, Annette Schroeter. United States Government Printing Office. Thomas F. Goldman, Henry R.
Property Services Agency Staff. Karl Popper. Geoffrey Boothroyd. Heather Chick. Botswana, Sept. Corey Sandler, Janice Keefe.
Sandra Labruce. Anne Barab, Tracy Brown, Bob Karstens, Karl J. Krayer, J. Maroney, Harriet Meyerson, Idell Moffett, Gary Rifkin, Mark J.
Sadlek, Ellen Spencer, Kelli S. Vrla, Rhonda Wildman. Amjad Umar. Bijan Jabbari. Jean Racine. Arthur Stanley Maxwell. David Carson. Margie Gray, Laura Ingalls Wilder.
Chris Etheridge. Cherryl Moote. Roy M. Don A. Stephen F. James Peter Stanton. Patti Spinelli. Jerry B. Day, Gunnison County Pioneer and Historical Society.
Paul Thompson, David Lane. Joy Perrine. Conrad Bishop, Elizabeth Fuller. Paul Jurmo, Sue Folinsbee, ABC Canada.
Don Ward. Francoise Wilhelmi de Toledo, Hubert Hohler. Jeff Savage. John Updike. Alexander Agricola.
Adam Gamble. Ibanga 1. Meir H. Jacques Werth, Nicholas E. Donna Leon. Beginner Believers Ministries, Incorporated.
Dennis F. Prentice Hall PTR. Neff, Scott H. Rose, Museum of Science and Industry Chicago, Ill.
FCO Services, Great Britain. Tom McLachlan, Kate Skye. James D. Halderman, Jim Linder. Catherine M. Stationery Office Staff. HSP, Harcourt School Publishers.
Ernest J. Edgar Ewing, Max F. Schulz, Fisher Gallery University of Southern California. Colin Barrow.
Paul Jensen. Sunbird Readers. Bruce W. David Krogh. Margaret Wise Brown. Peter Demetz. Aristides George Paradissis. Claudia Panuthos, Catherine Romeo.
John Winters, Maxine Barish-wreden, M. Storrs Charles H. Logan Associate Professor of Sociology University of Connecticut. Peter Honey, Alan Mumford.
Larry Marion. Peter A. McWilliams, Michael O'Rourke. Great Britain: Advisory, Conciliation and Arbitration Service.
John Santrock. National Aboriginal and Torres Strait Islander Program. Norman Crosby Getchell. Matthew Cornick. National Radiological Protection Board, Great Britain.
National Audit Office. Marisabina Russo. Que Lustrationes. Kieran O'Mahony, Rodney Broome. Carol A. Mik Schellback. Ed Wagner. Wallace Stegner.
Nicolaus Associates. Annie Wilder. Sven Nordqvist. William Somerset Maugham. Japan Publicity, Incorporated. Michael Leslie, Nicholas G.
Myra Goldberg. Max Weber. Teacher Guide,. Alice Barlow-Kedves. Roderick Hunt, David Hunt. Clare Moore, James Edward Moore. Penelope Williams.
Gene E. Pesticides Safety Directorate Staff. Richard Rice. Julie Tallard Johnson, Kristine Merrill, Jere Truer. Lloyd J. Dan Felder. Kevin Wolfe.
William L. There Is an Answer. Orchid Publishing Company. Patricia Irons. Martha S. Martin, Thomas H. Martin, Mark Charles Werthman. Committee on Foreign Relations.
Tami S. Karen Irvine, Patrick Thomas. Jill Franklin. Mohammad Hashim Kamali. Holly Devor. Del Hunter Morrill. David Snashall, Dipti Patel. Alice Bertha Gomme.
Gerry Mullins. NET 4. Jason N. Gaylord, Christian Wenz, Pranav Rastogi, Todd Miranda, Scott Hanselman. Harcourt Brace, Richard G. Elizabeth W.
Jeneanne Sieck. Ian Fleming. Sandy Baker. Ananda Breed. Hubert Campfens. Joe Upton. Richard C.
Michael Coleman. Rosemary Ashton. Richard E. Prior, Joseph Wohlberg. Aleksey D. Neil A. Campbell, Brad Williamson, Robin Heyden.
Kenneth H. Steven Carroll. Peter Cooper. Ridgeway, Gillian, Kathryn Harvey. Jane Kempf. Morter, Jr.. To do so, they employ strategies that invite visitors to experience themselves in relation to the collected objects, thereby rendering visitors in place and in time.
In this and other ways, the museums reproduce and consolidate normative conceptions of the individual, the community, of historical time, and of democracy.
As such, they participate in the maintenance and perpetuation of the very categories that most of us use to understand the world around us. Museums, like constitutions, function as authorizers of the world, its history, its reality, and its possibilities.
But museum scholar Donald Preziosi reminds us that the museum is not a singularly repressive institution. This tidy telos suggests that there are no remnants of apartheid within the new legal order.
The evolutionary force of this anamorphic orientation helps lend an authoritative gloss to the narrative of redemptive liberal democracy.
What is happening in these examples is a subjection of more fundamental questions of the political to the limited frameworks of statebased liberal democracy.
The museum staff frame the parameters of their political projects through the lens of governmental directives and constitutional fetishization. Representation, Sovereignty, and the Political To distinguish between politics and the political is to articulate a difference between the everyday concerns of institutional political activity politics , on the one hand, and considerations of ethics, thinking, writing, and acting that happen at a distance from such pre-existing, institutionally inclined parameters, on the other the political.
This difference is especially crucial for considering horizons of possibility that extend beyond the aims and objectives of representative democracy.
Without an autonomous and expansive concept of the political, imaginations of what is viable remain hopelessly tied to prevailing institutional norms and processes.
Both Schmitt and Arendt lament the colonization of an autonomous concept of the political by the utilitarian logic of the contemporary liberal nation-state.
My resistance to representation is not merely a groundless foray into the oceanic depths of postmodernism.
This project is important not only for societies where colonial contradictions endure, but also for other societies attempting to negotiate deep-seated historical divisions.
The limitations of a representation-centered approach are, in many ways, on display in the South African context. Over the past twenty years much has been written about the great potential and vast failures of the transformative constitutional project, a program that hinges on formal representation.
As I elaborate upon in chapter 4, though, twenty years later many of these racialized inequalities continue to persist. Constitutions alone cannot free people and heal divisions.
Such grandiose statements function as symbolic claims, meant to inspire a commitment to and an ethos of a social contract. But constitutions are not only symbolic; they are also documents that police.
Indeed, constitutions are authorized and enforced by a state that enacts them. They tell us who and what can be legally recognized and who and what is protected by their parameters: sovereign individuals living in a sovereign state.
Symbolically and materially, they request our investment in them, on their terms, and ask us to partake in a mutual monumental promise to their project of representation.
It is this mighty claim of the constitution and its place as the pinnacle of our collective political imagination that I take aim at in this book.
It is not only the constitution that sets its political aims as synonymous with institutional inclusion, however. The British Museum, like the local museum in Canada and the South African constitutional project, attempts to navigate legacies of empire by proffering better inclusion in its representational framework.
In chapter 2 I explain how the staff aim to bring nonwhite and immigrant individuals to the museum to counter its largely white and middle-class audience, as well as to promote a national agenda concerned with educational improvement.
Indeed, what these projects have in common is a belief in the power and potential of the instructional statement: YOU ARE HERE.
Maintaining this project of necessary delimitation as the pinnacle of our democratic aims and objectives is an impoverished conception of the possibilities of the political.
In response, this book articulates an alternative approach that takes the interruption of this liberal legal subject and its attendant political community as its task.
Such a project is necessary not only to avoid the suffocation of the political by politics, but also to interrupt the centrality of sovereignty in our political and juridical imaginations.
Of course, curating is a practice that is already popularly linked with museums. This book has a different focus: how the idea of community is curated at the site of the museum.
Rather than look to museum objects, this project looks at the interactive educational practices deployed in adult learning programs at museums.
As I explain in chapter 2, these programs are increasingly part of the modern museum experience and are presumed to help promote democratic engagement, diversity, and accessibility, elements that have long been noted as absent.
I argue that the interactive adult educational programming offered at museums often sets the production of community as its task.
Didier Maleuvre argues that museums invite visitors to identify with a prescribed set of political constituencies. Similarly, Preziosi argues that museums render people in place.
These orientations function as custodial tools in the production of an idea of community; they assist in its curation. By definition, the constitution bounds a body politic.
This book is concerned with the central role that the constitution plays in producing political community through a representational framework that valorizes sovereignty.
After all, both the museum and constitutionalism share in the creation of this horizon of intelligibility; they share in the production of imaginations of sovereignty.
By this I do not only mean the form of juridical sovereignty popularly linked with geopolitical authority, but also and especially the sovereignty that is imagined when we think of ourselves and the populations in which we claim status and belonging, whether state-based or not, as bounded or boundable.
Considering this commonality between the two institutions is crucial if we are serious about acknowledging the truth of our existence with each other and the world around us as relational.
It is not enough to only look to the constitution as the authenticator of the supremacy of the liberal individual and its corresponding community; we must also contemplate other sites that share a proclivity to launch imaginations of sovereignty.
Against Sovereignty This book reconsiders the political in order to challenge the purported necessity of representing community.
He argues that we need to ask tough questions about who and what these categories serve. For Nancy, this means that nothing can ever be absolutely bounded and delimited; it is always in relation to its outside.
Any postulation of a closed and atomized community or a closed and atomized individual is a denial of this relationality.
Community, like the individual, is without essence; it is nothing but infinite sharing brought about by the exposure of existence, and it is this infinite sharing that must be rendered legible.
Images of political communities and individuals, whether in constitutions or museum exhibitions, offer up mythological stories, authorized by an insidious and false equation of representation with truth.
To some, this will sound like new-age, apolitical, ahistorical balderdash. In my view, such a rethinking requires a thoroughgoing critique of the centrality of the sovereign individual at the heart of Western liberalism.
This figure is perpetuated in modern political theory as the unencumbered man that enters into the social contract for protection of property in themselves and their territory.
But for all the talk of protection that such arrangement achieves, it is precisely the political centrality of this imagined figure that continues to pose barriers to genuine forms of equity, not least because it is this thinking that perpetuates a durable mythology of individual and collective autonomy.
In so doing, we deny our relations with the world, telling lies about who and what is important, who and what needs protection, and who and what is affected by our actions.
Nor am I calling for an expansion of legal protections to include more natural features of the earth. What I am suggesting is that modern Western liberal law allows us to believe that justice is done when individual rights are protected, even at the expense of the world in which we live.
Anticolonial writers have long made this point. The authors show that, in negotiations with indigenous stakeholders, Canadian government lawyers draw lines as borders to divide up territory, cutting communities off from vital connections to water systems and animal migratory routes.
This simple example crystallizes the discord between worldviews and what is at stake in such untranslatability.
To engage with a liberal legal system is to participate in the recasting of cultural presumptions that flow from that tradition, such as the veneration of human lives above all others, the centrality of the liberal individual subject, and the dominion of human-drawn borders.
Many other critiques of the legacy of sovereignty and the subject at its center in Western legal and political thinking have since emerged from anticolonial writers in North America such as Taiaiake Alfred, Glen Coulthard, John Borrows, Audra Simpson, and Andrea Smith.
Ramose in particular develops a sustained critique of the heritage of the liberal individual, especially as it takes its form in the grammar of Western law.
Language is indispensable to the indelible inscription of the legal subject into the vocabulary of law. I draw inspiration from his work as I challenge the centrality of the constitution, with all its culturally inflected presuppositions, especially in postapartheid theories of law and jurisprudence that come from South Africa.
Cultural assumptions about liberal legal justice as superior have long fueled dismissive reactions to anticolonial critique, and it is my aim to forefront what is at stake in and offer some alternatives to this repudiation.
Perhaps obviously then, I do not argue that the mere inclusion of constitutional principles inflected with indigenous overtones is a useful strategy for a decolonial project.
The problem, as I emphasize throughout, is that the fundamental logic of the liberal legal system turns on a sovereign individual subject that is contained within a sovereign legal community.
Incorporating indigenous concepts like ubuntu cannot disrupt the foundational presuppositions of the liberal paradigm. I explain this in greater detail, using two case studies, in chapter 5.
This is also why extra-legal sites are important and why, for the purposes of this research, I turn to the museum as a site in the contemporary moment that can offer more thoughtful reflection on the inheritance of liberal epistemological tenets than the constitution can.
Moreover, it is not only the liberal individual subject that is a barrier to anticolonial thinking. Rather, the target herein is the figure of sovereignty as absolute, whether individual or collective, and this takes form in many places, not just the constitution.
As I explain in greater detail in chapter 1, the paradox of the absolute confounds any attempt to draw a border around someone or some thing, including community.
Sovereign declarations tell a lie about the possibility of the impossible absolute. But this assertion may rub some readers the wrong way.
One hundred times, yes. But this strategy must also be clear-minded about what it is: a foray into a legal system that hinges on the mythological figure of the absolute.
It seems that its deployment is only useful in a world where these precepts continue to have hold on our imaginations, in a sense, only in enemy terrain; while it may be a necessary tool for confronting liberal legal systems in a recognizable language, it can only offer solutions on the terms of that same system.
This means a redeployment of the mythological figures of the individual and community that rest at its center, which continue to act as barriers to a philosophy of being-in-common, which in turn stifles the potential for decolonization and environmental justice.
Therefore, my aim is not constitutions per se, but rather the narratives of sovereignty that they import. Other devices can also import these stories and do.
Indeed, this is what museums and constitutions have in common. They both have the potential to tell a myth about community, whether that be on state-based, ethnic, or anthropocentric lines.
The propensity to tell these stories is also found in political movements and populist uprisings; it is certainly not confined to the constitution.
In short, the constitution is the legal authorizer of the myth of sovereignty. Although such myths circulate elsewhere, including museums, they do not have to.
It is this potential that I explore herein. Countermonumental Constitutionalism This challenge to the thinking of the sovereign individual and its attendant community poses a dilemma for constitutionalism.
For how can the constitution, the framework for the articulation of political community par excellence, avoid the inevitable delimitation of political community?
In short, it cannot. In this book I contend that the museum is more able to attend to this need for radical reflexivity because it has the potential to interrupt steady, strong, sovereign conceptions of political community.
I therefore bring the museum and the constitution together to pursue a theory of countermonumental constitutionalism that serves as a resource in the production of nonsovereign imaginations of community.
They respectively turn to human obligation, an Arendtian conception of politics, and art as other modes of effecting national responsibility for democracy and resisting what le Roux calls constitutional spectatorship.
Countermonumental constitutionalism in this book is made up of two components. First, a countermonumental constitutionalism does not exalt the constitution as the central tool in the production of political community.
The museum plays a crucial role in this respect because it demonstrates that the constitution is not the only place from which imaginations of political community are launched.
Remembering that political community is a product of practices at multiple sites works against the inclination to fetishize the constitutional arrangement as its central orienting tool.
The second component of a countermonumental constitutionalism is the necessary interruption of community. The museum is key in this regard because, unlike the constitution, it has the capacity to facilitate this interruption.
Indeed, while the museum, like the constitution, tends to set the production of community as its task, it can also engage in countermonumental memorializing practices that disrupt this persistent aim.
The cultivation of these practices and their insistent interrogation of the logic of communion can offer a crucial supplement to the limits of constitutionalism.
Museums thus offer the possibility of holding open the political rather than letting it be subsumed by politics. I apply this theory of a countermonumental constitutionalism to recently articulated postapartheid theories of law.
These theories, proffered by Johan van der Walt and by Drucilla Cornell and Nyoko Muvangua, articulate a postapartheid jurisprudence based on amendments to the adjudication process.
In their respective arguments, these scholars attempt to locate the possibility of a more just South Africa through legal judgments that go beyond the protection of liberal democratic rights.
But while these theories make significant efforts to hold the political open, they ultimately cannot for two major reasons.
First, they maintain the centrality of the constitution in their theories. By focusing solely on the possibilities of adjudication to reconstruct a more just South Africa, they recenter the constitutional arrangement as the primary tool for such practices.
Second, while they are critical of the limits of this constitution, their theories do not engage in the undoing of its central communing logic.
This move forgoes a retreatment of the political. In contrast, a countermonumental constitutionalism can provide a helpful alternative.
Such an approach introduces the site of the museum as a place that can also build imaginations of political community.
But rather than build coherent and smooth sovereign imaginations, the museum can be tasked with pulling apart these imaginations in an attempt to undo the logic of communion.
The District Six Museum in South Africa offers a key example of how such countermonumental practices can be exercised.
This museum is actively engaged in the undoing of conceptions of community. While the museum is committed to revisiting history in the hopes of building an anticapitalist and anti-apartheid South Africa, it is also wary of the dangers of too easily falling into simple conceptions of history and community.
This is particularly important for the staff as the landscapes of trauma and violence are layered with multiple and competing claims to land and history.
Therefore, they simultaneously launch programs that interrogate notions of community, home, and race while also attempting to build an anti-apartheid city.
I elaborate on these critical memorializing practices in detail in chapters 3 and 4. In sum, pairing the museum with the constitution affords two vital opportunities.
First, it decenters the constitution as the central tool in the production of political community. Second, the museum offers an external resource that can provide reflexive reconsiderations of community that the constitution cannot.
In its reflexive role, however, the museum is not intended to augment or add to the constitution. I am not calling for a radical dispersion of public life into privatized identity politics.
Rather, my concern is passionately invested in the public sphere, who and what we think it includes and how it is maintained.
Constitutions offer a supposedly universal method of communicating what the essential parts of our public is made up of, what basic tenets we can all agree to.
But what do we do with those humans, nonhumans, and philosophies that are always already sidelined from this public due to a historically and culturally particular European predilection for sovereignty?
My argument is that we need to maintain a role for the constitution, for these articulations of publicness, but that because it is a legal document that necessary delineates, necessarily cuts, it cannot also be the device that interrupts imaginations of sovereignty.
The constitution cannot simultaneously delimit and offer reflexivity upon that closure; it is not structurally designed for this purpose.
Surely, some will retort that all representation delineates, that all institutionalization is necessarily reductionist.
It is my view, however, that not all institutions are equally reductive. Where the constitution must, the museum can do otherwise.
The museum is not structurally bound to offer the same neat story of sovereignty. Countless annual school trips from elementary to college age often integrated with state-legislated curriculum , as well as tourist visits promoted by municipal, state, and federal governments, mean that the museum is a vibrant venue for thinking about popular conceptions of community but also a locus for effectively interrupting those conceptions.
While other sites might also serve as productive places from which sovereign imaginations of community can be disturbed, I retain a focus on the museum precisely because of its place as a common and quasi-official authorizer of truth.
This project thus takes seriously the question of being-in-common in the ontological realm, but only as it has ramifications for the ontic.
In this vein, my argument seems more akin to an Arendtian one: critique sovereignty, yes, but hold on to some semblance of order, or, in her words, promises in a sea of insecurity.
Constitutions are here now and not going anywhere quickly. The challenge then, I argue, is to simultaneously use them, acknowledge the hold they have on our collective imaginations as the pinnacle devices with which we organize society, and to disrupt that grip.
This is not a flippant dismissal of these lauded documents but rather a passionate concern with the ways in which constitutional precepts actively condition horizons of legal and political intelligibility.
If we want to imagine differently, I argue, we must confront our attachment to these documents and their imported language, subject, jurisdiction, and remedies.
This is a difficult argument to hold together; the first three chapters develop a critique of the constitution, while the latter two endorse its continued role in the contemporary moment.
I demonstrate in those early chapters the extent and significance of the limits of representation in the project of transformation. Chapter 1 introduces the tension between politics and the political by turning to political theorists and philosophers who have commented on the distinction over the course of the past century.
Significantly, this tension has animated much of the theory concerned with themes of freedom, sovereignty, and community.
These thinkers, such as Schmitt and Arendt, are also concerned with a thinking of constitutionalism, its role, its potential, and its limitations.
Indeed, the tension between politics and the political animates much of constitutional thought, as scholars attempt to pair expansive notions of freedom with the limits imposed on this freedom by law.
Contemporary constitutional thinkers Martin Loughlin, Neil Walker, and Emilios Christodoulidis also attempt to address this tension.
Each specifically acknowledges the limits of the constitution and then attempts to address this limitation through the constitutional arrangement itself or by turning to the politics of civil society.
Both of these moves, however, remain focused on the production of community with the liberal individual subject at its center, when what is needed is a constitutionalism that can write the interruption of community.
Chapter 2 explores how the theme of community persists through the rise of the modern museum, as well as in calls for its reform.
Like the constitutionalism articulated by scholars in chapter 1, these orientations function to close down the world rather than open it up.
Retreating the political means reapproaching these assumptions in order to more fully attend to their limits and to contemplate more expansive conceptions of the new, democratic museum.
In the case of constitutionalism, the notion of enduring time lends legitimacy to the authority of the state. In the case of the museum, chronological time is used to produce categories of community and the individual.
In both cases, self-assured conceptions of past, present, and future are used to legitimize a narrow concept of the political.
Yet these anamorphic orientations cannot entirely smooth and cohere the world. Indeed, my research at the British Museum also yields examples of unexpected confusion, miscommunication, and frustration between staff members and participants that interrupt the anamorphic proclivities of the museum.
But although these sporadic events offer momentary contestations to the authority of chronological time, they do not go far enough in articulating the interruption of community.
Chapter 4 demonstrates that articulating the interruption of community can take place through countermonumental memorializing practices at the museum.
Although the museum, like the constitution, attempts to smooth the world through frameworks of sovereignty, there are also ways for it to resist this tendency.
Countermonumental practices, such as those observed through the interactive adult educational programming at the District Six Museum, intentionally disrupt the cohering of community.
And these practices have real ramifications for constitutionalism. Christodoulidis, a key critic of constitutional fetishism, looks to the potential of civil society to challenge the limits of the constitutional framework.
He argues that the powers of civil society, organized into a collective subject, offer the possibility of resistance. But while Christodoulidis engages in a critique of constitutional monumentalism, he ultimately endorses a monumental politics, one that hinges on the absolute immanence of the multitude that he derives from the work of Antonio Negri.
Rather than function in contradistinction to constitutionalism, a theory of politics motivated by a collective subject falls prey to the same dilemma of producing community.
Chapter 5 draws on existing South African constitutional theory to fully articulate a theory of countermonumental constitutionalism.
Adjuvant denosumab in breast cancer ABCSG : a multicentre, randomised, double-blind, placebo-controlled trial. Gnant, M, Pfeiler, G, Dubsky, PC, Hubalek, M, Greil, R, Jakesz, R, Wette, V, Balic, M, Haslbauer, F, Melbinger, E, Bjelic-Radisic, V, Artner-Matuschek, S, Fitzal, F, Marth, C, Sevelda, P, Mlineritsch, B, Steger, GG, Manfreda, D, Exner, R, Egle, D, Bergh, J, Kainberger, F, Talbot, S, Warner, D, Fesl, C, Singer, CF.
Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model. Gassner FJ, Zaborsky N, Catakovic K, Rebhandl S, Huemer M, Egle A, Hartmann TN, Greil R, Geisberger R.
Epub May 4. AIDing cancer treatment: Reducing AID activity via HSP90 inhibition. Rebhandl, S, Geisberger, R.
Eur J Immunol. Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Gnant, M, Sestak, I, Filipits, M, Dowsett, M, Balic, M, Lopez-Knowles, E, Greil, R, Dubsky, P, Stoeger, H, Rudas, M, Jakesz, R, Ferree, S, Cowens, JW, Nielsen, T, Schaper, C, Fesl, C, Cuzick, J.
ANN ONCOL. Oncogenic role of miR in anaplastic large cell lymphoma lacking the t 2,5 translocation. Merkel, O, Hamacher, F, Griessl, R, Grabner, L, Schiefer, AI, Prutsch, N, Baer, C, Egger, G, Schlederer, M, Krenn, PW, Hartmann, TN, Simonitsch-Klupp, I, Plass, C, Staber, PB, Moriggl, R, Turner, SD, Greil, R, Kenner, L.
J Pathol. Ein Konsensusstatement]. Lindner, C, Dierneder, J, Pall, G, Pirich, C, Hoffmann, M, Raderer, M, Becherer, A, Niederle, B, Lipp, R, Lind, P, Gallowitsch, H, Romeder, F, Virgolini, I.
Kern, D, Regl, G, Hofbauer, SW, Altenhofer, P, Achatz, G, Dlugosz, A, Schnidar, H, Greil, R, Hartmann, TN, Aberger, F.
CD18 ITGB2 expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms. Hutterer, E, Asslaber, D, Caldana, C, Krenn, PW, Zucchetto, A, Gattei, V, Greil, R, Hartmann, TN.
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
Them, NC, Bagienski, K, Berg, T, Gisslinger, B, Schalling, M, Chen, D, Buxhofer-Ausch, V, Thaler, J, Schloegl, E, Gastl, GA, Wolf, D, Strecker, K, Egle, A, Melchardt, T, Burgstaller, S, Willenbacher, E, Zagrijtschuk, O, Klade, C, Greil, R, Gisslinger, H, Kralovics, R.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin"s lymphoma GHSG HD13 : an open-label, randomised, non-inferiority trial.
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Knauer, M, Moik, M, Jakesz, R, Seifert, M, Taucher, S, Bjelic-Radisic, V, Balic, M, Eidtmann, H, Eiermann, W, Steger, G, Kwasny, W, Dubsky, P, Selim, U, Fitzal, F, Hochreiner, G, Wette, V, Sevelda, P, Ploner, F, Bartsch, R, Fesl, C, Greil, R.
IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer-Results of a case series after 5-year follow-up.
Fastner, G, Reitsamer, R, Ziegler, I, Zehentmayr, F, Fussl, C, Kopp, P, Peintinger, F, Greil, R, Fischer, T, Deutschmann, H, Sedlmayer, F. Int J Cancer.
Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab: A Phase II Trial.
Pircher, M, Mlineritsch, B, Fridrik, MA, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Rinnerthaler, G, Ressler, S, Ulmer, H, Greil, R.
A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?.
Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Berghoff, AS, Preusser, M, Greil, R, Hopfinger, G. Adipocyte-derived players in hematologic tumors: useful novel targets?.
Expert Opin Biol Ther. A phase 1 dose escalation study of BI , an inhibitor of Aurora kinase B, in patients with advanced solid tumors.
Dittrich, C, Fridrik, MA, Koenigsberg, R, Lee, C, Goeldner, R, Hilbert, J, Greil, R. Invest New Drugs. Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.
Acta Diabetol. Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.
Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Morre, P, Boekstegers, A, Hopfinger, G, Auberger, J, Steinkirchner, S, Pleyer, L, Greil, R, Egle, A.
Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of cases. Berghoff, AS, Ilhan-Mutlu, A, Dinhof, C, Magerle, M, Hackl, M, Widhalm, G, Hainfellner, JA, Dieckmann, K, Pichler, J, Hutterer, M, Melchardt, T, Bartsch, R, Zielinski, CC, Birner, P, Preusser, M.
Neuropathol Appl Neurobiol. VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.
Hinterseer, E, Stiefel, O, Neureiter, D, Kandler, G, Vogt, S, Hutter, J, Strasser, G, Greil, R, Hartmann, TN, Hopfinger, G.
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.
Blank, PR, Filipits, M, Dubsky, P, Gutzwiller, F, Lux, MP, Brase, JC, Weber, KE, Rudas, M, Greil, R, Loibl, S, Szucs, TD, Kronenwett, R, Schwenkglenks, M, Gnant, M.
Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study. Longitudinal analysis of NSCLC patients: a comprehensive study from the TYROL registry.
Kocher, F, Hilbe, W, Seeber, A, Pircher, A, Schmid, T, Greil, R, Auberger, J, Nevinny-Stickel, M, Sterlacci, W, Tzankov, A, Jamnig, H, Kohler, K, Zabernigg, A, Frotscher, J, Oberaigner, W, Fiegl, M.
LUNG CANCER. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur, D, Angelova, O, Orth-Holler, D, Ditlbacher, A, Lackner, M, Auberger, J, Lass-Florl, C. EUR J HAEMATOL. Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction.
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.
Wasle, I, Gamerith, G, Kocher, F, Mondello, P, Jaeger, T, Walder, A, Auberger, J, Melchardt, T, Linkesch, W, Fiegl, M, Mian, M. Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.
Sochalska, M, Tuzlak, S, Egle, A, Villunger, A. Kocher, T, Asslaber, D, Zaborsky, N, Flenady, S, Denk, U, Reinthaler, P, Ablinger, M, Geisberger, R, Bauer, JW, Seiffert, M, Hartmann, TN, Greil, R, Egle, A, Hofbauer, JP.
Rebhandl, S, Huemer, M, Greil, R, Geisberger, R. Renaissance eines alten Bekannten - Bedeutung des Androgenrezeptors beim Mammakarzinom. Wiener klinisches Magazin.
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria. Clin Lymphoma Myeloma Leuk. Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.
Leierer, G, Grabmeier-Pfistershammer, K, Steuer, A, Geit, M, Sarcletti, M, Haas, B, Kanatschnig, M, Rappold, M, Zangerle, R, Ledergerber, B, Taylor, N.
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan, KT, Melchardt, T, Deutsch, A, Schlick, K, Stojakovic, T, Bullock, MD, Reitz, D, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Egle, A, Pichler, M.
Eur J Haematol. The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia. Gutjahr, JC, Greil, R, Hartmann, TN.
FRONT IMMUNOL. The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M.
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Ludwig, H, Greil, R, Masszi, T, Spicka, I, Shpilberg, O, Hajek, R, Dmoszynska, A, Paiva, B, Vidriales, MB, Esteves, G, Stoppa, AM, Robinson, D, Chaturvedi, S, Ataman, O, Enny, C, Feng, H, van de Velde, H, Viterbo, L.
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.
Jaeger, U, Trneny, M, Melzer, H, Praxmarer, M, Nawarawong, W, Ben Yehuda, D, Goldstein, D, Mihaljevic, B, Ilhan, O, Ballova, V, Hedenus, M, Hsiao, LT, Au, WY, Burgstaller, S, Weidinger, G, Keil, F, Dittrich, C, Skrabs, C, Klingler, A, Chott, A, Fridrik, MA, Greil, R.
How does lenalidomide target the chronic lymphocytic leukemia microenvironment? Kater, AP, Tonino, SH, Egle, A, Ramsay, AG, Blood. Epub Aug Old and new news in CLL: "It"s the pathway, stupid!
Egle, A, Blood. CLL cells under flow. Hartmann TN Blood. Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia.
Bevacizumab BEV plus chemotherapy CT continued beyond first disease progression PD in patients with metastatic colorectal cancer mCRC previously treated with BEV-based therapy: Outcomes according to KRAS status and first-line CT backbone in the ML study.
Kubicka, S, Greil, R, Andre, T, Bennouna, J, Sastre, J, Van Cutsem, E, Von Moos, R, Osterlund, PJ, Hegde, P, Sersch, MA, Osborne, S, Hermann, F, Arnold, D J CLIN ONCOL.
Ebenfalls in Pubmed gefunden: Eur J Cancer. Epub Sep Updated report of the Austrian CML registry Schmidt, S, Sill, H, Greil, R, Burgstaller, S, Sliwa, T, Petzer, A, Lang, A, Weltermann, A, Voskova, D, Mitterer, M, Valent, P, Eberhard, N, Walder, A, Geissler, K, Andel, J, Hausler, C, Ludescher, C, Oexle, H, Korger, M, Schnallinger, M, Schreieck, S, Krippl, P, Pober, M, Woell, E, Geissler, D, Rochau, U, Siebert, U, Thaler, J, Gastl, G ONCOL RES TREAT.
Malignant Lymphoblasts in T Cell Acute Lymphoblastic Leukemia Express High Levels of Kv1. Epub Dec Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?
Gampenrieder, SP, Rinnerthaler, G, Greil, R Breast Care Basel. Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Epub Nov Huemer F, Gampenrieder SP, Schlattau A, Greil R. Clin Breast Cancer. Int J Oncol. Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz.
Geretti AM, Conibear T, Hill A, Johnson JA, Tambuyzer L, Thys K, Vingerhoets J, Van Delft Y J Antimicrob Chemother. Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.
Fiegl M, Stauder R, Steurer M, Mian M, Hopfinger G, Brychtova Y, Skrabs C, Zabernigg A, Schmid F, Haslbaur F, Winder G, Walder A, Lang A, Voskova D, Greil R, Mayer J, Gastl G Ann Hematol.
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC and UCHL1.
Mod Pathol. Epub Dec 6. Tecemotide L-BLP25 versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer START : a randomised, double-blind phase 3 trial.
Epub Dec 9. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, et al.
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.
Taylor N, Haschke-Becher E, Greil R, Strasser M, Oberkofler H. Antivir Ther. Epub Jan Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.
Guglielmelli P, Biamonte F, Rotunno G, Artusi V, Artuso L, Bernardis I, Tenedini E, Pieri L, Paoli C, Mannarelli C, Fjerza R, Rumi E, Stalbovskaya V, Squires M, Cazzola M, Manfredini R, Harrison C, Tagliafico E, Vannucchi AM Blood.
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res. Epub Feb Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Pleyer L, Germing U, Sperr WR, Linkesch W, Burgstaller S, Stauder R, Girschikofsky M, Schreder M, Pfeilstocker M, Lang A, Sliwa T, Geissler D, Schlick K, Placher-Sorko G, Theiler G, Thaler J, Mitrovic M, Neureiter D, Valent P, Greil R.
Effect of radiotherapy after mastectomy and axillary surgery on year recurrence and year breast cancer mortality: meta-analysis of individual patient data for women in 22 randomised trials.
EBCTCG Early Breast Cancer Trialists' Collaborative Group , McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.
Epub Mar Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Epub May 5. Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives.
Hohla F, Winder T, Greil R, Rick FG, Block NL, Schally AV. World J Gastroenterol. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, et al.
N Engl J Med. Epub May Oxaliplatin, fluorouracil and leucovorin with or without cetuximab in patients with resected stage III colon cancer PETACC-8 : an open-label randomised phase 3 trial.
Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C Lancet Oncol.
Epub Jun Azacitidine in patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays, an ERIC-wide approach. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II IIIA and IIIB TAX-AT 1.
Kocher F, Pircher A, Mohn-Staudner A, Romeder F, Duller W, Steinmaurer M, Eckmayr J, Schmid T, Hilbe W, Fiegl M, Greil R. Lung Cancer.
Epub Jul 3. A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?
Schlick K, Troch M, Placher-Sorko G, Faber V, Neureiter D, Berghoff AS, Preusser M, Greil R, Hopfinger G. Epub Jul MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.
Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW, Byrd JC Br J Haematol. Epub Aug 8.
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. Benboubker L, Dimopoulos MA, Dispenzieri A, Catalano J, Belch AR, Cavo M, Pinto A, Weisel K, Ludwig H, Bahlis N, Banos A, Tiab M, Delforge M, Cavenagh J, Geraldes C, Lee JJ, Chen C, Oriol A, de la Rubia J, Qiu L, White DJ, Binder D, et al.
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. Brodowicz T, Lang I, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Petruzelka L, Eniu A, Anghel R, Koynov K, Vrbanec D, Pienkowski T, Melichar B, Spanik S, Ahlers S, Messinger D, Inbar MJ, Zielinski C.
Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer - A Phase II Clinical Trial.
Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients.
Blank PR, Filipits M, Dubsky P, Gutzwiller F, Lux MP, Brase JC, Weber KE, Rudas M, Greil R, Loibl S, Szucs TD, Kronenwett R, Schwenkglenks M, Gnant M.
Dittrich C, Fridrik MA, Koenigsberg R, Lee C, Goeldner R, Hilbert J, Greil R. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma GHSG HD13 : an open-label, randomised, non-inferiority trial.
Pleural decortication of a marginal zone lymphoma. Melchardt T, Weiss L, Namberger K, Pretsch I, Hutter J, Rettenbacher L, Neureiter D, Troch M, Greil R, Egle A.
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma. Weiss L, Melchardt T, Habringer S, Boekstegers A, Hufnagl C, Neureiter D, Hopfinger G, Greil R, Egle A.
Epub Dec 3. Human immunodeficiency virus type 2 infections in Austria. Taylor N, Kern JM, Prammer W, Lang A, Haas B, Gisinger M, Zangerle R, Egle A, Greil R, Oberkofler H, Eberle J.
Liver toxicity during temozolomide chemotherapy caused by Chinese herbs. Melchardt T, Magnes T, Weiss L, Grundbichler M, Strasser M, Hufnagl C, Moik M, Greil R, Egle A.
BMC Complement Altern Med. Melchardt T, Weiss L, Hufnagl C, Neureiter D, Kemmerling R, Morre P, Boekstegers A, Hopfinger G, Auberger J, Steinkirchner S, Pleyer L, Greil R, Egle A.
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan KT, Schlick K, Deutsch A, Melchardt T, Egle A, Stojakovic T, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Pichler M.
Kasabach-Merritt phenomenon in hepatic angiosarcoma. Habringer S, Boekstegers A, Weiss L, Hopfinger G, Meissnitzer T, Melchardt T, Egle A, Greil R.
Them NC, Bagienski K, Berg T, Gisslinger B, Schalling M, Chen D, Buxhofer-Ausch V, Thaler J, Schloegl E, Gastl GA, Wolf D, Strecker K, Egle A, Melchardt T, Burgstaller S, Willenbacher E, Zagrijtschuk O, Klade C, Greil R, Gisslinger H, Kralovics R.
Epub Mar 2. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study ABCSG Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M Ann Oncol.
Hofbauer SW, Krenn PW, Ganghammer S, Asslaber D, Pichler U, Oberascher K, Henschler R, Wallner M, Kerschbaum H, Greil R, Hartmann TN.
Epub Feb 5. Hutterer E, Asslaber D, Caldana C, Krenn PW, Zucchetto A, Gattei V, Greil R, Hartmann TN. Epub Oct Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Knauer, M, Moik, M, Jakesz, R, Seifert, M, Taucher, S, Bjelic-Radisic, V, Balic, M, Eidtmann, H, Eiermann, W, Steger, G, Kwasny, W, Dubsky, P, Selim, U, Fitzal, F, Hochreiner, G, Wette, V, Sevelda, P, Ploner, F, Bartsch, R, Fesl, C, Greil, R Ann Oncol.
Hinterseer E, Stiefel O, Neureiter D, Kandler G, Vogt S, Hutter J, Strasser G, Greil R, Hartmann TN, Hopfinger G.
Targeting proliferation of chronic lymphocytic leukemia CLL cells through KCa3. Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.
Rebhandl S, Huemer M, Zaborsky N, Gassner FJ, Catakovic K, Felder TK, Greil R, Geisberger R. Epub Apr APOBEC3 signature mutations in chronic lymphocytic leukemia.
Huemer M, Rebhandl S, Zaborsky N, Gassner FJ, Hainzl S, Weiss L, Hebenstreit D, Greil R, Geisberger R. Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.
Gassner FJ, Zaborsky N, Neureiter D, Huemer M, Melchardt T, Egle A, Rebhandl S, Catakovic K, Hartmann TN, Greil R, Geisberger R.
Protein Kinase C-? B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo.
Cancer Cell. Valente LJ, Gray DH, Michalak EM, Pinon-Hofbauer J, Egle A, Scott CL, Janic A, Strasser A. Cell Rep. Epub May 9. Bid-ding for mercy: twisted killer in action.
Egle A, Asslaber D, Villunger A, Pinon-Hofbauer J. Cell Death and Differentiation. Melchardt, T, Weiss, L, Egle, A, Dtsch Med Wochenschr.
Epub Oct 1. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
Zucchetto A, Caldana C, Benedetti D, Tissino E, Rossi FM, Hutterer E, Pozzo F, Bomben R, Dal Bo M, D'Arena G, Zaja F, Pozzato G, Di Raimondo F, Hartmann TN, Rossi D, Gaidano G, Del Poeta G, Gattei V.
Updated report of the Austrian CML registry Schmidt, S, Burgstaller, S, Linkesch, W, Greil, R, Schlogl, E, Fridrik, M, Krieger, O, Petzer, A, Lang, A, Mitterer, M, Valent, P, Walder, A, Sliwa, T, Keil, F, Korger, M, Hausler, C, Woll, E, Oexle, H, Schnallinger, M, Pober, M, Rochau, U, Siebert, U, Thaler, J, Gastl, G ONKOLOGIE.
Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy - A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie Pircher, M, Mlineritsch, B, Fridrik, M, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Ressler, S, Rinnerthaler, G, Ulmer, H, Greil, R ONKOLOGIE.
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: updated results from a retrospective matched-pair analysis Gampenrieder, SP, Romeder, F, Muss, C, Pircher, M, Ressler, S, Rinnerthaler, G, Bartsch, R, Sattlberger, C, Mlineritsch, B, Greil, R Anticancer Res.
Two patients diagnosed with coexisting hematologic and oncologic BRAF VE mutated malignancies. Which entity is really carrying the BRAF VE mutation?
Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Greil, R, Hopfinger, G ONKOLOGIE.
Aktuelle Diagnostik und Therapieoptionen bei aggressiven Lymphomen. Hopfinger, G, Greil, R Bremen, London, Boston: UniMed Verlag, Mycophenolatmofetil und Azathioprin in der Schwangerschaft bei einer Patientin mit systemischem Lupus erythematodes.
Psenak, O, Studnicka-Benke, A, Greil, R Rheuma plus. Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Dubsky P, Filipits M, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Kronenwett R, Brase JC, Gnant M Ann Oncol.
Epub Oct 3. Randomized phase II study of bortezomib, thalidomide and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.
Ludwig H, Viterbo L, Greil R, Masszi T, Spicka I, Shpilberg O, Hajek R, Dmoszynska A, Paiva B, Vidriales MB, Esteves G, Stoppa AM, Robinson D Jr, Ricci D, Cakana A, Enny C, Feng H, van de Velde H, Harousseau JL.
Continuation of bevacizumab after first progression in metastatic colorectal cancer ML : a randomised phase 3 trial.
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial ABCSG 8.
Goetz MP, Suman VJ, Hoskin TL, Gnant M, Filipits M, Safgren SL, Kuffel M, Jakesz R, Rudas M, Greil R, Dietze O, Lang A, Offner F, Reynolds CA, Weinshilboum RM, Ames MM, Ingle JN.
Epub Dec 4. Topical evening primrose oil for reduction of bortezomib-induced skin reactions. Auberger J, Vogt S, Hopfinger G, Clausen J, Greil R.
Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study. J Clin Microbiol. A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p.
Namberger K, Weiss L, Krause B, Melchardt T, Greil R. Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label non-inferiority phase 3 TURANDOT trial.
Lang I, Brodowicz T, Ryvo L, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Zvirbule Z, Steger GG, Melichar B, Pienkowski T, Sirbu D, Messinger D, Zielinski C Lancet Oncol.
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials. Ring David Crippen David Crolla David Cronenberg David Crook David Crowe David Crowther David Cruz-Uribe David Cry David Crystal David C.
Sigee David C. Spellmeyer David C. Spencer David C. Sprigings David C. Swanson David C. Swinney David C. Thompson David Cunningham David Curran David Currie David Curtis David Cutler David C.
Wilcox David C. Wiley David C. Woodman David C. Wyld David Daley David Damas David Damrosch David Damschroder David Dannheisig David Dante Troutt David Darling David Darmofal David Davies David D'Avray David D.
Awschalom David Day David D. Briske David D. Burns David D. Busch David D. Celentano David D. Cunningham David Deamer David Dean Bottrell David Deardorff David De Cremer David Dee David Degenhardt David Degner David Degrazia David Deida David Dejour David De Las Morenas David Demaree David Denk David Dent David Denunzio David Denver David Derbes David Dernie David De Rothschild David Derovan David De Smet David De Stefano David Detmer David Deutsch David Devlaeminck David Dewar David D.
Friedman David D. Gilmore David D. Hall David D. Hanagal David Dickinson David Diduch David Divalerio David D. Nolte David Doane David Dobson David Dolby David Dolinak David Donachie David Donald David Dosa David Dossot David Dougan David Douglas David Dowling David Downie David Downing David Downs David Doyle David D Perlmutter David D Peterson David Drabe David Dreman David Drew David D.
Riley David Dryden Davidds David D. Alexander Davide Ambrosi David E. Armstrong David Easley David E. Aune David E. Ballantine Davide Balzarotti David E.
Barclay Davide Bigoni David E. Bock David E. Booher David E. Brandt David Ebrey Davide Buscaldi Davide Calvaresi David E. Carter David E. Chinitz Davide Chiumello Davide Ciucci David Eckersall David E.
Clark David E. Clarke Davide Comoretto David Eddie David Edelman David E. Dematthews Davide Deriu David Edge David Edgerton Davide Di Gennaro Davide Dionisi David Edmond David Edmonds David Edward Marcinko David Edwards David Edwin Pingree David E.
Eisner David E Elder David E. Elder David E. Elkins Soc Davide Fiscaletti David E. Fisher David E. Fishman David E.
Garland Davide Giovanni Papa Davide Giuriato David E. Golan David E Gray David E. Guest David E. Gussak David E. Hatch David E. Hiebeler David E.
Hoffman David Eimer David Einhorn David Eisenbud David E. James David E. Jones David E. Klemm David E. Kyvig David E.
Laughlin David E. Lewis David Eliezer David Elizandro David Ellgering David Elliott David Ellis David Ellwood David Ellyard David Emanuel Hoffman Davide Martino David Embick David E.
Mcadams David E Mcclean David E. Mccraw David E. Mcnabb Davide Michieletto David Emin David E. Mohrman Davide Moraschi David E. Morrison Iii David E.
Mulcahy David E. Murphy David Enders David E. Newton David England David Enoch David Enrich David E.
Nye Davide Orsi David E. Perry David E. Platt David E. Pollard David E. Polley David Epstein David E.
Radcliffe David E. Reisner David Erik Nelson Davide. Rizzato David E. Rowe David E. Rye David E Sadava David E.
Sadava David E. Sahn David E. Scharff Davide Schiffer David E. Schoonover David E. Schroeder David Escors Davide Scullino Davide Secchi David Eshel David E.
Shi Davide Sivolella Davide Spallazzo David Espinet David Esseni David Estlund David E. Sumner David E. Sutton David E.
Swayne David Etheridge Devid David Etheridge Etheridge David E. Traul Davide Turcato David Eugene Smith Davide Vampa David E. Vance David Evanier David Evans Davide Viaggi Davide Vigetti David E.
Wellbery David E. Wesson David E. Wilkins David E. Laidler David E. Sarna David E. Zimerman David FöRster David Fairer David Fallon David F.
Anderson David Fanning David Farber David Farland David Farrell Krell David Farrusseng David F. Bateman David F. Burg David F.
Carr David F. Ciambrone David F. D'Alessandro David Fee David Feinleib David Feinstein David Feldman David Fergusson David Fernbach David Ferry David F.
Ford David F. Griffiths David F. Groebner David F. Hendry David F. Horrobin David Finkelhor David Firestone David Fisher David Fiske David Fitzgerald David Flanagan David F.
Lancy David Flannery David Fleet David Fleming David Fletcher David Flink David Floyd David Flynn David F Manlove David F.
Marley David F. Mazurek David F. Noble David Foenkinos David Folkenflik David Fontana David Ford David Forrest David Forsyth David Foskett David Foster Wallace David F.
Ostwald David Foulkes David Fouto David Fox David Fox David F. Parkhurst David F. Parmelee David F. Peelo David F. Pelly David F.
Pierre Jr David France David Francis Curran David Fraser David Frawley David Frayne David Frederick Ross David French David Frenkiel David Friedman David Friend David Frum David F.
Schmitz David F. Stroncek David F. Tolin David F. Tver David Fung David Furch David Gabai David Gadd David Gaines David Gale David Galef David Galens David Gamble David Game David G.
Anderson David G. Andrews David Gange David Gardner David Garduno Barrera David Garets David Garrow David Gates David Gauntlett David G.
Aviv David Gaynes David G. Barrie David G. Blanchflower David G Blumenkrantz David G. Bolgiano David G. Bromley David G. Burke David G.
Carmichael David G. Chandler David G. Chapple David G Collings David G. Collings David G. Costa David Geary David Gebler David Geiger David Gelles David Genecov David Gentilcore David George Gordon David George Haskell David George Surdam David Gero David Gethin John David G.
Gillam David G Gilmore David G. Greenhalgh David G. Gutierrez David G. Hebert David G. Hull David G. Hunter David Gibbings David Gibson David Gilbarg David Gilbert David Gill David Gillard David Gillen David Giller David Gillespie David Gilliam David Gillies David Gillota David Gilmartin David Gilmour David Ginley David G.
Scott David Gissen David G. Kleinbaum David Glasser David Glauser David Gledhill David Glen Mick David Glick David G.
Luenberger David G Mcafee David G. Morgan-Owen David G. Ostrow David Gottlieb David Gould David Govrin David Gower David Gowler David G.
Peterson David Gradwell David Graeber David Graham David Grambs David Gramling David Grann David Grant David Gray David Grazian David Green David Greenberg David Greentree David Greenwood David Gregory David Greig David Grembowski David Greven David G.
Ries David Gries Auth. David Griffeath David Griffith David Griffiths David Grinspoon David Gromer David Groome David G. Roskies David Grotto David Grove David Grubbs David Grusky David G.
Schaeffer David G. Schrunk David G. Simons David G. Smith David G. Stern David G. Taylor David G. Thomson Davidg. Tompkins David G. Tuerck David Gullette David G Ullman David G.
Vermette David G. Allen David Halliday David Hally David Halpern David H. Alpers David Halsey David Hambling David Hamilton David Hammond David Hanan David Hancock David Hanlon David Hann David Hannay David Hanson David Harap David Hardwick David Hardy David Harel David Harland Rousseau David Harmon David Harp David Harper David Harries David Harris David Harrison David Harte David Hartsough David Harvey David Haslam David Hassan David Hatherly David Haven Blake David Hawkes David Hay David Haynes David Haywood Young David H.
Bailey David H. Barlow David H. Bennett David H. Boal David H. Chestnut David H. Clark David H. Cropley David H. Darrow David Head David Healy David H.
Eberly David Hecker David Heffelfinger David Held David Heller David Hempleman-Adams David Hencke David Henig David Henley David Henry David Hepworth David Herbert Somerset Cranage David Herd David Herman David Herres David Herzog David H.
Evans David Hewitt David Hewson David Hey David H. Liu David H. Friedman David H. Hubel David Higgs David Hilborn David Hill David Hillier David Hilton David Hindley David Hinton David Hirsh David Hitchcock David H.
Jackson David H. Kim David H. Kirn David H. Laidlaw David H. Levy David H. Lyth David H. Murdoch David Ho David Hobbs David Hockney David Hodge David Hodgson David Hoffeld David Hoffman David Hoffmann David Holcman David Hollar David Hollenberg David Holmgren David Holston David Holton David Hone David Hooper David Hopkins David Hornung David Horowitz David Horrobin David Horsager David Horspool David Horton Smith David Houle David House David Howard David Howard Bain David Howard Davis David Howard Gelin David Howarth David Howden David Howell David H.
Owens David Howie David Howlett David Hows David H. Persing David H. Phillips David H. Ramirez David H. Richter David H. Ringstrom David H.
Rosenthal David H. Ross David H. Sandler David H. Sattinger David H Sharp David H. Sharp David Hsu David H.
Wong David Hu David Hucaby David Huddart David Huebert David Hugh Bunnell David Hui David Hulme David Hume David Hundt David Hunt David Hunter-Chester David Hurst Thomas David Hutchison David Huxley David H.
Weis David Hyman David Ian Gibson David Ian Starling David Ian Wimpenny David I. Bainbridge David I. Bernstein David Icke David I Cleland David I.
Cleland David Igler David I. Hanauer David I Harvie David I. Mostofsky David I. Olive David Ip David I. Rome David Irving David I.
Soybel David J. Abner David J. Clines David J. Clines David Jacobs David Jacoby David J. Adelstein David Jaher David J. Alworth David James David James Fenech David James Kelly David James Martin David Jamieson Bolder David Japy David Jason David Jason Karp David Jasper David Jauss David Jay Brown David Jay Green David J.
Baker David J. Balding David J. Ballard David J. Barnes David J. Bartholomew David J. Benson David J Bercuson David J. Bland David J. Bodenhamer David J Breeze David J.
Breeze David J. Callans David J. Cast David J. Cole-Hamilton David J. Collins S. David J. Cook David J. Dandy David J. Darling David J.
Dowrick David J. Driscoll David J. Drucker David Jefferis. David Jeffrey David J. Eicher David Jeremiah David J. Garrow David J. Gibson David J.
Gilchrist David J. Gingery David J. Goldberg David J. Goleman David J. Griffiths David J Gross David J. Gunkel David J.
Hak David J. Hand David J Harvey David J. Harvey David J. Haskins David Jhave Johnston David J. Helfand David J. Hess David J. Howe David J. Hunter Davidji David Jin David J.
Jepsen David J. Balfour David J. Kenney David J. Kerr David J. Klotzkin David J. Laporte David J. Leffell David J.
Leonard David J. Ley David J. Lieberman David J. Linden David J Liptrot David J.